Mr. Keith Westby, M.B.A. has been the Chief Operating Officer and Senior Vice President of Ophthotech Corporation since January 30, 2017. Mr. Westby served as Senior Vice President of Development Operations at Ophthotech Corporation since October 2014 until January 2017. Mr. Westby served as Vice President of Project Management at Ophthotech Corporation and also served as its Senior Director of Project Management. Mr. Westby has more than 10 years of experience in project and strategic alliance management and manufacturing operations in Biotech companies. Mr. Westby most recently served at Pharmasset, Inc., as Director, Project and Alliance Management, accountable for developing and implementing strategy across manufacturing, research and development, preclinical, clinical, regulatory and finance for both internal and partnered projects. Prior to that, Mr. Westby served in positions of increasing responsibility at Eyetech Pharmaceuticals from January 2002 to December 2005, most recently as Director, Alliance & Project Management, leading multifunctional project teams in the NDA filing and marketing approval of Macugen® for Age-Related Macular Degeneration. Previously, Mr. Westby served at Tunnell Consulting from 1997 to 2002, where he served as a Senior Consultant in Life Sciences practice focused on manufacturing operations and process improvement. Mr. Westby holds a B.S. in Applied Physics from the State University of New York, College at Geneseo, an M.S in Engineering Management from Drexel University and an MBA from Columbia Business School. Mr. Keith Westby, M.B.A. has been the Chief Operating Officer and Senior Vice President of Ophthotech Corporation since January 30, 2017. Mr. Westby served as Senior Vice President of Development Operations at Ophthotech Corporation since October 2014 until January 2017. Mr. Westby served as Vice President of Project Management at Ophthotech Corporation and also served as its Senior Director of Project Management. Mr. Westby has more than 10 years of experience in project and strategic alliance management and manufacturing operations in Biotech companies. Mr. Westby most recently served at Pharmasset, Inc., as Director, Project and Alliance Management, accountable for developing and implementing strategy across manufacturing, research and development, preclinical, clinical, regulatory and finance for both internal and partnered projects. Prior to that, Mr. Westby served in positions of increasing responsibility at Eyetech Pharmaceuticals from January 2002 to December 2005, most recently as Director, Alliance & Project Management, leading multifunctional project teams in the NDA filing and marketing approval of Macugen® for Age-Related Macular Degeneration. Previously, Mr. Westby served at Tunnell Consulting from 1997 to 2002, where he served as a Senior Consultant in Life Sciences practice focused on manufacturing operations and process improvement. Mr. Westby holds a B.S. in Applied Physics from the State University of New York, College at Geneseo, an M.S in Engineering Management from Drexel University and an MBA from Columbia Business School.

Ophthalmic Pathology